Uniquely positioned as one of Asia’s most experienced research houses, our dedicated team has an extensive presence in 14 markets across Asia and covers more than 800 stocks across the region. Its deep connectivity enables a more robust coverage model and produce research on ecosystems and thought leadership for our institutional clients.
Macquarie ranked 1st in Extel’s 2025 Asia (ex-Japan/ANZ) Local Broker rankings1, achieving the highest points in the weighted leaders’ table and the greatest number of ranked analysts by sector across 11 countries/regions.
In addition to our long-standing country insights, our team also focuses on 4 sector verticals: technology and software, energy transition and commodities (ETAC), consumer and healthcare. Our proprietary data sets and analysis help our clients with their investment processes to generate alpha.
On-the-ground insights on strong thematic verticals
Differentiated coverage on 800-plus stocks across Asia
Providing specialist coverage of key verticals including Technology, Energy Transition & Commodities, Consumer, and Healthcare
Asia's investment landscape is subject to rising cross currents that require specific insights from the ground.
The conference will bring together on-the-ground insights with our extensive research footprint across Asia focusing on four core verticals - Tech & Software, Energy Transition & Commodities, Consumer, and Healthcare - as well as tangible market access to key corporates and C-suites, expert speakers, and bespoke tours to provide you with actionable investment ideas.
Hangzhou's tech scene is now a thriving ecosystem of innovative unlisted start-ups including DeepSeek, Game Science and Unitree Robotics.
A handful of private companies known as 'Six Little Dragons' have captured media attention, causing investors to re-assess China's long-term total factor productivity via AI and robotics.
Interested in this article but not a Macquarie client? Contact our team.
We analyse the secret sauce that has allowed successful Asia brands to grow beyond their home markets and capture market share globally.
Interested in this article but not a Macquarie client? Contact our team.
AI and other new technologies across various semiconductor manufacturing steps are pushing the industry beyond Moore’s Law, which has driven progress historically though is today facing diminishing returns. With these performance gains slowing, the industry is turning to new technologies to continue scaling and improving efficiency.
Interested in this article but not a Macquarie client? Contact our team.
Our bottom-up forecast shows AI driving datacentre power demand doubling to ~3% of global demand by 2028. This presents immense opportunities for companies that can facilitate this growth, and for those that can invest in them. It also exacerbates challenges for power grids worldwide, already struggling to cope with the energy transition after years of underinvestment.
Interested in this article but not a Macquarie client? Contact our team.
Despite tempering market expectations, we remain bullish on electric-vehicle industry growth. Demand for electric vehicles (EVs) continues amid falling battery prices, new models, the move to price parity, and increasing fast-charging capacity.
Interested in this article but not a Macquarie client? Contact our team.
The automobile market in Asia is leading the global transition from internal combustion engine vehicles to electric (and hybrid) vehicles. While competition amongst manufacturers, greater consumer choice and maturing battery supply chains have driven the mass market adoption of EVs in China, affordability and the slower pace of behaviour change have seen more limited uptake in developed markets like the Americas and Europe.”
James Hong,
Head of Asia Energy Transition and Commodities
The recovery of the consumer market in China is likely to be uneven, with high-end and mass-end consumption outperforming that in the middle; lower-tier cities outperforming higher-tier ones; and demand during holiday periods outperforming. Even though we believe service consumption remains resilient and we could see secular recovery with the growth of education, travel and entertainment.”
Linda Huang,
Head of Asia Consumer Research
Asian biopharmaceutical and medical device firms are quickly becoming a key source of innovation as the industry grapples with expiring patents and falling drug prices; the decoupling of the healthcare supply chain is also creating winners and losers. We are excited about the tremendous investment opportunities healthcare in Asia could offer.”
Tony Ren,
Head of Asia Healthcare Research
The next 5-10 years will see large, sustained investment in technology and chipmaking capacity, aimed at enabling diffusing advanced data processing from the network edge to the cloud. We expect significant activity to be directed at discovering and exploiting at scale the business opportunities enabled by the flood of data from sensors and online activity.”
Damian Thong,
Division Director, Senior Research Analyst
We aim to provide the most interesting, thought-provoking research in Asia – the kind that investors want to read out of intellectual curiosity, not just for investment ideas.”
Christina Lee,
Head of Asia Content (Research & Sales)
Macquarie Capital
Technology
Arthur Lai
Consumer
Linda Huang
Critical Minerals and Energy Transition
James Hong
ESG
Charles Yonts
Healthcare
Tony Ren
ASEAN
Jayden Vantarakis
Global Strategy
Viktor Shvets
